YU41829B - Process for obtaining penicillanic acid 1,1-dioxide drivatives - Google Patents

Process for obtaining penicillanic acid 1,1-dioxide drivatives

Info

Publication number
YU41829B
YU41829B YU1170/78A YU117078A YU41829B YU 41829 B YU41829 B YU 41829B YU 1170/78 A YU1170/78 A YU 1170/78A YU 117078 A YU117078 A YU 117078A YU 41829 B YU41829 B YU 41829B
Authority
YU
Yugoslavia
Prior art keywords
drivatives
dioxide
obtaining
penicillanic acid
penicillanic
Prior art date
Application number
YU1170/78A
Other languages
English (en)
Other versions
YU117078A (en
Inventor
W E Barth
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27122691&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU41829(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of YU117078A publication Critical patent/YU117078A/xx
Publication of YU41829B publication Critical patent/YU41829B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
YU1170/78A 1977-06-07 1978-05-16 Process for obtaining penicillanic acid 1,1-dioxide drivatives YU41829B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80432077A 1977-06-07 1977-06-07
US87938178A 1978-02-21 1978-02-21

Publications (2)

Publication Number Publication Date
YU117078A YU117078A (en) 1983-01-21
YU41829B true YU41829B (en) 1988-02-29

Family

ID=27122691

Family Applications (1)

Application Number Title Priority Date Filing Date
YU1170/78A YU41829B (en) 1977-06-07 1978-05-16 Process for obtaining penicillanic acid 1,1-dioxide drivatives

Country Status (35)

Country Link
AR (1) AR224111A1 (ko)
AT (2) AT360649B (ko)
AU (1) AU513636B2 (ko)
BE (1) BE867859A (ko)
BG (2) BG34614A3 (ko)
CH (1) CH634073A5 (ko)
CS (1) CS208472B2 (ko)
DD (2) DD148585A5 (ko)
DE (2) DE2824535C3 (ko)
DK (1) DK155740C (ko)
EG (1) EG13869A (ko)
FI (1) FI66003C (ko)
FR (2) FR2393804A1 (ko)
GB (1) GB2000138B (ko)
GR (1) GR72255B (ko)
HK (1) HK13184A (ko)
HU (1) HU180042B (ko)
IE (1) IE47079B1 (ko)
IL (2) IL54867A (ko)
IN (1) IN149747B (ko)
IT (1) IT1096381B (ko)
KE (1) KE3355A (ko)
LU (1) LU79774A1 (ko)
MY (1) MY8500092A (ko)
NL (2) NL180009C (ko)
NO (2) NO151746C (ko)
NZ (1) NZ187476A (ko)
OA (1) OA05964A (ko)
PH (3) PH26810A (ko)
PL (1) PL114501B1 (ko)
PT (1) PT68146A (ko)
SE (2) SE436206B (ko)
SG (1) SG65383G (ko)
SU (1) SU860706A1 (ko)
YU (1) YU41829B (ko)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77306A1 (ko) * 1977-05-09 1979-01-18
DE2912511C2 (de) * 1977-06-07 1982-06-24 Pfizer Inc., 10017 New York, N.Y. Pharmazeutische Zusammensetzung, enthaltend Penicillansäure
DK155942C (da) * 1977-12-23 1989-10-23 Pfizer Analogifremgangsmaade til fremstilling af 6-aminopenicillansyre-1,1-dioxid og fysiologisk acceptable syreadditions- og basesalte deraf.
JPS54126735A (en) * 1978-03-24 1979-10-02 Toyama Chem Co Ltd Bactericidal composition for medical use
US4241050A (en) * 1978-09-01 1980-12-23 Pfizer Inc. Penam 1,1-dioxides as beta-lactamase inhibitors
CA1158639A (en) * 1978-12-11 1983-12-13 Eric M. Gordon 6-bromopenicillanic acid sulfone
IE49880B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd Penicillin derivatives
SE449103B (sv) * 1979-03-05 1987-04-06 Pfizer Sett att framstella penicillansyra-1,1-dioxid samt estrar derav
US4714761A (en) * 1979-03-05 1987-12-22 Pfizer Inc. 6,6-dihalopenicillanic acid 1,1-dioxides and process
US4420426A (en) 1979-03-05 1983-12-13 Pfizer Inc. 6-Alpha-halopenicillanic acid 1,1-dioxides
GB2045236A (en) * 1979-03-26 1980-10-29 Hoechst Uk Ltd Oxapenem derivatives
US4244951A (en) 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4309347A (en) * 1979-05-16 1982-01-05 Pfizer Inc. Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide
IE49770B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
DE3051044C2 (ko) * 1979-06-19 1989-03-30 Leo Pharmaceutical Products Ltd. A/S (Loevens Kemiske Fabrik Produktionsaktieselskab), Ballerup, Dk
US4256733A (en) * 1979-09-26 1981-03-17 Pfizer Inc. Acetoxymethyl penam compounds as β-lactamase inhibitors
US4432970A (en) * 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
IL61880A (en) * 1980-01-21 1984-11-30 Bristol Myers Co 2beta-chloromethyl-2alpha-methylpenam-3alpha-carboxylic acid sulfone derivatives,their preparation and pharmaceutical compositions containing them
US4488994A (en) * 1980-09-08 1984-12-18 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4432903A (en) * 1980-09-08 1984-02-21 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4474698A (en) * 1980-12-11 1984-10-02 Pfizer Inc. Process for preparing esters of penicillanic acid sulfone
US4419284A (en) * 1981-03-23 1983-12-06 Pfizer Inc. Preparation of halomethyl esters (and related esters) of penicillanic acid 1,1-dioxide
EP0069962B1 (en) * 1981-07-15 1985-01-02 Kanebo, Ltd. Novel ester of 1,1-dioxopenicillanic acid, process for production thereof, and use thereof as beta-lactamase inhibitor
PT76526B (en) * 1982-04-19 1986-01-21 Gist Brocades Nv Preparation of 6-alpha-bromo- and/or 6,6-dibromopenicillanic acid 1,1-dioxides
US4502988A (en) * 1983-08-08 1985-03-05 Eli Lilly And Company Oxidation process
EP0139047A1 (en) * 1983-10-18 1985-05-02 Gist-Brocades N.V. Process for the preparation of 6,6-dibromopenicillanic acid 1,1-dioxide
US4647457A (en) * 1983-12-16 1987-03-03 Hoffmann-La Roche Inc. Penicillanic acid derivatives
JPH07103129B2 (ja) * 1986-04-10 1995-11-08 レオ・ファーマシューティカル・プロダクツ・リミテッド・エイ／エス（レーベンス・ケミスケ・ファブリック・プロデュクチオンスアクチーセルスカブ） ペニシラン酸誘導体の改良された新規合成方法
GB8808701D0 (en) * 1988-04-13 1988-05-18 Erba Carlo Spa Beta-lactam derivatives
CN102977120B (zh) * 2012-12-14 2015-05-27 江西富祥药业股份有限公司 一种舒巴坦匹酯制备及结晶方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197466A (en) * 1961-10-30 1965-07-27 Smith Kline French Lab Penicillin sulfoxides and process
LU77306A1 (ko) * 1977-05-09 1979-01-18
AU3796278A (en) * 1977-07-13 1980-01-17 Glaxo Group Ltd Penams and azetidinones

Also Published As

Publication number Publication date
GB2000138B (en) 1982-03-03
DK155740C (da) 1989-10-23
AT360649B (de) 1981-01-26
DE2824535B2 (de) 1980-05-14
FR2393805B1 (ko) 1984-02-24
AT364084B (de) 1981-09-25
SE447995B (sv) 1987-01-12
PH16465A (en) 1983-10-20
PL114501B1 (en) 1981-02-28
DD140888A5 (de) 1980-04-02
FR2393805A1 (fr) 1979-01-05
FI781800A (fi) 1978-12-08
IL62168A0 (en) 1981-03-31
FI66003B (fi) 1984-04-30
HK13184A (en) 1984-02-24
DK251478A (da) 1978-12-08
IT1096381B (it) 1985-08-26
SE8305916L (sv) 1983-10-27
LU79774A1 (fr) 1980-01-22
AU513636B2 (en) 1980-12-11
DD148585A5 (de) 1981-06-03
GB2000138A (en) 1979-01-04
NL930064I2 (nl) 1994-04-18
NO823126L (no) 1978-12-08
CS208472B2 (en) 1981-09-15
BG34615A3 (en) 1983-10-15
IT7824270A0 (it) 1978-06-06
NL7806126A (nl) 1978-12-11
IL54867A (en) 1981-11-30
IE781140L (en) 1978-12-07
SE7806628L (sv) 1978-12-08
HU180042B (en) 1983-01-28
SE8305916D0 (sv) 1983-10-27
BG34614A3 (en) 1983-10-15
IL54867A0 (en) 1978-08-31
ATA411278A (de) 1980-06-15
NZ187476A (en) 1982-08-17
CH634073A5 (en) 1983-01-14
DE2824535C3 (de) 1981-01-22
DE2824535A1 (de) 1978-12-14
PH26810A (en) 1992-11-05
IN149747B (ko) 1982-04-03
NO781970L (no) 1978-12-08
DK155740B (da) 1989-05-08
SG65383G (en) 1985-03-29
IE47079B1 (en) 1983-12-14
FR2393804A1 (fr) 1979-01-05
NO151746C (no) 1985-06-05
ATA128580A (de) 1981-02-15
BE867859A (fr) 1978-12-06
AU3683878A (en) 1979-12-06
FR2393804B1 (ko) 1980-11-07
SU860706A1 (ru) 1981-08-30
OA05964A (fr) 1981-06-30
NO152448B (no) 1985-06-24
NO152448C (no) 1985-10-02
NO151746B (no) 1985-02-18
SE436206B (sv) 1984-11-19
DE2857263B2 (de) 1981-04-23
AR224111A1 (es) 1981-10-30
GR72255B (ko) 1983-10-06
YU117078A (en) 1983-01-21
PH21116A (en) 1987-07-16
DE2857263C3 (de) 1981-12-17
FI66003C (fi) 1984-08-10
NL180009C (nl) 1986-12-16
KE3355A (en) 1983-12-16
PT68146A (en) 1978-07-01
EG13869A (en) 1983-03-31
MY8500092A (en) 1985-12-31
NL930064I1 (nl) 1993-09-01
PL207396A1 (pl) 1979-06-04

Similar Documents

Publication Publication Date Title
YU41829B (en) Process for obtaining penicillanic acid 1,1-dioxide drivatives
YU127478A (en) Process for obtaining 1,2,3-thiadiazole-5-carboxylic acid derivatives
PT68515A (en) Process for preparing thiazine derivatives.
YU294978A (en) Process for preparing new 4-hydroxy-2h-1,2-benzothiazine-3-carboxamide-1,1-dioxides
YU42807B (en) Process for preparing phthalazine-4-yl-acetic acid derivatives
HU177900B (en) Process for preparing 7alpha-methoxy-7beta-malonamido-3-/1,3,4-thiadiazoly-5-yl/-thiomethy/-1-dethia-1-oxa-3-cefem-4-carboxylic acid derivatives
HU178811B (en) Process for producing di-n-propyl-acetic acid
YU41015B (en) Process for obtainig 2-formqequinoxaline -1,4-dioxyde cyanoacetylhydrazone
YU44663B (en) Process for obtaining 4-substituted imidazo /1,2a/ hynoxaline
YU134877A (en) Process for obtaining 3,4-dihydro-2-methyl-4-oxo-2h-1,2-benzothiazine-3-carboxylic acid 1,1-dioxide
DE2860056D1 (en) Process for the preparation of thienopyridine derivatives.
PH14096A (en) N-9,10-dihydrolysargyl-m-aminobenzoic acid dmide derivative
YU220282A (en) Process for producing 2,3-dicyanopyrazine derivatives
YU54178A (en) Process for obtaining 2,1,3-thiadiazine-4-one-2,2-dioxide deerivatives
JPS53128610A (en) Process for making fireeresistant moloings
PT67783A (en) Process for preparing oleanoic acid derivatives
GB2008116B (en) Process for preparing 2,5-diketogluconic acid
YU57478A (en) Process for obtaining 1,2,3-thiadiazoline-2-ide derivatives
YU40418B (en) Process for obtainining halo-oxazoline derivatives
GB2000499B (en) Process for producing alpha-monochloroacetoacetic acid monomethylamide
YU40474B (en) Process for obtaining amoxicillin
KE3489A (en) 7alpha-methoxy-7beta-(1,3-dithietane-2-carboxamido)cephalosporanic acid derivatives
YU32578A (en) Process for preparing 3-carboyphenyl-acetic acid derivatives
YU42379B (en) Process for obtaining di-n-propylacetic acid
HU173661B (hu) Sposob poluchenija proizvodnykh 7-beta-skobka-skobka-2-amino-1,2-dioksi-etil-skobka zakryta-amino-skobka zakryta-3-metil-cef-3-em-4-karbonovojj kisloty